|
VVOS Vivos Therapeutics Inc 1716166 |
| Income Statement |
|
Revenue
|
form10-q
|
3,860,000 |
|
Net Income
|
form10-q
|
-2,616,000 |
|
Profit Margin
|
|
-67.77% |
| Balance Sheet |
|
Current Assets
|
7,399,000 |
|
Assets
|
15,347,000 |
|
Current Liabilities
|
5,126,000 |
|
Liabilities
|
7,682,000 |
|
Equity
|
7,665,000 |
|
Shares Out
|
3,401,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-9,751,000 |
|
Investing Cash Flow
|
-403,000 |
| Market Analysis |
Market Cap
|
9,558,181 |
|
Price
|
3.70 |
|
BVPS
|
2.25 |
|
PB
|
1.57 |
|
EPS
|
-6.98 |
|
PS
|
0.62 |
|
FCF
|
-10,154,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VVOS documents filed with the SEC.
VVOS Filings
Clear
